Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes

BJU International

Volumn 112, Issue 5, 2013, Pages 623-637

  Rink, Michael ^a,d   Xylinas, Evanguelos ^a,e   Trinh, Quoc Dien ^f   Lotan, Yair ^b   Margulis, Vitaly ^b   Raman, Jay D ^c   Fisch, Margit ^d   Lee, Richard K ^a   Chun, Felix K ^d   Abdennabi, Joual ^h   Seitz, Christian ⁱ   Pycha, Armin ^j   Zlotta, Alexandre R ^g   Karakiewicz, Pierre I ^f   Babjuk, Marko ^k   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Paris Descartes University ^*  (France)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j CENTRAL HOSPITAL OF BOLZANO   (Italy)

^k UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

more..

Author keywords

dose relationship; gender; radical nephroureterectomy; recurrence; smoking; survival; transitional cell carcinoma; upper urinary tract; urothelial carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SMOKING HABIT; TRANSITIONAL CELL CARCINOMA; TUMOR NECROSIS;

DOSE RELATIONSHIP; GENDER; RADICAL NEPHROURETERECTOMY; RECURRENCE; SMOKING; SURVIVAL; TRANSITIONAL CELL CARCINOMA; UPPER URINARY TRACT; UROTHELIAL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SEX FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; URETERAL NEOPLASMS; UROTHELIUM;

EID: 84882284805     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12014     Document Type: Article

References (38)

1. Cha EK, Shariat SF, Kormaksson M, et al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 2012; 61: 818-825
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233
3. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
4. Colin P, Koenig P, Ouzzane A, et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 2009; 104: 1436-1440
5. Pommer W, Bronder E, Klimpel A, et al. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 1999; 14: 2892-2897
6. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29
7. McLaughlin JK, Silverman DT, Hsing AW, et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992; 52: 254-257
8. Rink M, Xylinas E, Margulis V, et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol 2012 [Epub ahead of print]
9. Fernandez MI, Shariat SF, Margulis V, et al. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology 2009; 73: 142-146
10. Lughezzani G, Sun M, Perrotte P, et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology 2010; 75: 321-327
11. Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 2011; 29: 481-486
12. Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999; 86: 2337-2345
13. Lammers RJ, Witjes WP, Hendricksen K, et al. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol 2011; 60: 713-720
14. Sturgeon SR, Hartge P, Silverman DT, et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994; 5: 218-225
15. Thompson IM, Peek M, Rodriguez FR,. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. J Urol 1987; 137: 401-403
16. Fajkovic H, Halpern JA, Cha EK, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011; 29: 457-463
17. Roscigno M, Shariat SF, Margulis V, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 2009; 56: 512-518
18. Chromecki TF, Cha EK, Fajkovic H, et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 2012; 61: 245-253
19. Hellenthal NJ, Shariat SF, Margulis V, et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 2009; 182: 900-906
20. Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer (AJCC) Staging Manual, 7th edn. New York: Springer, 2010
21. Eble JN, Sauter G, Epstein JI, Sesterhenn IA,. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARCC Press, 2004
22. Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 2009; 103: 307-311
23. Kikuchi E, Margulis V, Karakiewicz P, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-618
24. Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575-581
25. Raman JD, Ng CK, Scherr DS, et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010; 57: 1072-1079
26. Rink M, Ehdaie B, Cha EK, et al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 2012; 62: 677-684
27. Rink M, Fajkovic H, Cha EK, et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 2012; 61: 854-855
28. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC,. Association between smoking and risk of bladder cancer among men and women. JAMA 2011; 306: 737-745
29. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E,. Smoking and prostate cancer survival and recurrence. JAMA 2011; 305: 2548-2555
30. Kim HT,. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007; 13: 559-565
31. Cokkinides V, Bandi P, McMahon C, et al. Tobacco control in the United States-recent progress and opportunities. CA Cancer J Clin 2009; 59: 352-365
32. Bostrom PJ, Alkhateeb S, Trottier G, et al. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. BJU Int 2011; 109: 70-76
33. Jiang X, Castelao JE, Yuan JM, et al. Cigarette smoking and subtypes of bladder cancer. Int J Cancer 2012; 130: 896-901
34. Bolenz C, Lotan Y, Ashfaq R, Shariat SF,. Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol 2009; 56: 1093-1095
35. Mir C, Shariat SF, van der, Kwast TH, et al. Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int 2011; 108: 24-30
36. Miyamoto H, Yao JL, Chaux A, et al. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 2012; 109: 1716-1726
37. Shariat SF, Sfakianos JP, Droller MJ, et al. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010; 105: 300-308
38. Ferrucci L, Izmirlian G, Leveille S, et al. Smoking, physical activity, and active life expectancy. Am J Epidemiol 1999; 149: 645-653